Evidence map›Paper›PMID 34122560›Full record

ArticleJournal of tropical medicine2021

Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children.

Randula Ranawaka, Chamara Jayamanne, Kavinda Dayasiri, Dinuka Samaranayake, Udara Sandakelum, Wathsala Hathagoda, Ruwangi Dissanayake, Pujitha Wickramasinghe

Open access · goldAbstract read
In one paragraph

Article in Journal of tropical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Randula RanawakaDepartment of Paediatrics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.ORCID https://orcid.org/0000-0002-4382-489X
Chamara JayamanneUniversity Paediatric Unit, Lady Ridgeway Hospital for Children, Colombo, Sri Lanka.ORCID https://orcid.org/0000-0001-8256-6021
Kavinda DayasiriUniversity Paediatric Unit, Lady Ridgeway Hospital for Children, Colombo, Sri Lanka.ORCID https://orcid.org/0000-0003-0438-9837
Dinuka SamaranayakeUniversity Paediatric Unit, Lady Ridgeway Hospital for Children, Colombo, Sri Lanka.ORCID https://orcid.org/0000-0001-5950-3874
Udara SandakelumDepartment of Paediatrics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.ORCID https://orcid.org/0000-0002-2663-4429
Wathsala HathagodaDepartment of Paediatrics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.ORCID https://orcid.org/0000-0002-3567-0069
Ruwangi DissanayakeDepartment of Paediatrics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.ORCID https://orcid.org/0000-0003-2770-3235
Pujitha WickramasingheDepartment of Paediatrics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.ORCID https://orcid.org/0000-0002-8355-1283
Lady Ridgeway Hospital for Children · LKUniversity of Colombo · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogenesis of dengue haemorrhagic fever is not fully understood, but it is thought that there is antibody enhancement during the secondary infection, which causes severe dengue haemorrhagic fever (DHF). Therefore, patients who have DHF should have a documented history of symptomatic dengue infection in the past. A retrospective descriptive-analytical study was conducted at the University Paediatric Unit at Lady Ridgeway Hospital for Children, Colombo, Sri Lanka. All children who had fulfilled the criteria for DHF admitted to the unit from April 2018 to September 2018 were recruited into the study. Relevant data were collected from bed head tickets. One hundred and eighty-four children were included in the final analysis. Thirty-three (17.9%) had a past history of documented symptomatic dengue infection, while 82.1% did not have a documented dengue infection. Twelve patients had dengue shock syndrome, and none of them had previously documented symptomatic dengue fever. Dextran was used in 96 patients in the critical phase. Twelve (42%) patients with past documented symptomatic dengue fever needed dextran while 84 (54.9%) patients without a documented past history of dengue fever needed dextran. In our clinical observation, we noticed that children with DHF mostly did not have a documented symptomatic prior dengue infection, while those with a documented symptomatic prior infection had a milder subsequent illness. In fact, the majority (82.1%) of patients with DHF did not have documented previous symptomatic dengue infection. It was also observed that the clinical course of subsequent dengue infection was less severe in patients with previously documented symptomatic dengue fever. This finding should be further evaluated in a larger scale study minimizing the all-confounding factors. This fact is more important in selecting recipients for vaccines against the dengue virus, which are supposed to produce immunity against the virus without causing the severe disease.

Identifiers

PMID34122560
PMCPMC8192182
OpenAlexW3169434610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.